These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Abrogation of afferent lymph dendritic cell function after cutaneously applied chemical carcinogens. Ragg SJ; Dandie GW; Woods GM; Muller HK Cell Immunol; 1995 Apr; 162(1):80-8. PubMed ID: 7704915 [TBL] [Abstract][Full Text] [Related]
4. Topical retinoic acid inhibits changes in Langerhans cell density during carcinogenesis. Halliday GM; McKay DA In Vivo; 1993; 7(3):271-6. PubMed ID: 8357969 [TBL] [Abstract][Full Text] [Related]
5. Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion. Woods GM; Qu M; Ragg SJ; Muller HK Immunology; 1996 May; 88(1):134-9. PubMed ID: 8707340 [TBL] [Abstract][Full Text] [Related]
6. Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate. Halliday GM; Dickinson JL; Muller HK Immunology; 1989 Jul; 67(3):298-302. PubMed ID: 2759656 [TBL] [Abstract][Full Text] [Related]
7. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
8. Migration of Langerhans cells from carcinogen-treated sheep skin. Dandie GW; Ragg SJ; Muller HK J Invest Dermatol; 1992 Nov; 99(5):51S-53S. PubMed ID: 1431210 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of benzo[a]pyrene and dimethylbenz[a]-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis. Ruby JC; Halliday GM; Muller HK J Invest Dermatol; 1989 Feb; 92(2):150-5. PubMed ID: 2493054 [TBL] [Abstract][Full Text] [Related]
10. Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells. Qu M; Muller HK; Woods GM Carcinogenesis; 1997 Jun; 18(6):1277-9. PubMed ID: 9214614 [TBL] [Abstract][Full Text] [Related]
11. The migration of Langerhans' cells into and out of lymph nodes draining normal, carcinogen and antigen-treated sheep skin. Dandie GW; Watkins FY; Ragg SJ; Holloway PE; Muller HK Immunol Cell Biol; 1994 Feb; 72(1):79-86. PubMed ID: 7512535 [TBL] [Abstract][Full Text] [Related]
12. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576 [TBL] [Abstract][Full Text] [Related]
13. Suppressor cell activation and enhanced skin allograft survival after tumor promotor but not initiator induced depletion of cutaneous Langerhans cells. Halliday GM; Odling KA; Ruby JC; Muller HK J Invest Dermatol; 1988 Mar; 90(3):293-7. PubMed ID: 2964490 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis. Halliday GM; Lucas AD Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587 [TBL] [Abstract][Full Text] [Related]
15. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein. Rambukkana A; Pistoor FH; Bos JD; Kapsenberg ML; Das PK Lab Invest; 1996 Feb; 74(2):422-36. PubMed ID: 8780161 [TBL] [Abstract][Full Text] [Related]
16. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice. Atarashi K; Kabashima K; Akiyama K; Tokura Y Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185 [TBL] [Abstract][Full Text] [Related]